BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 22038757)

  • 1. Mild isolated craniosynostosis due to a novel FGFR3 mutation, p.Ala334Thr.
    Barroso E; Pérez-Carrizosa V; García-Recuero I; Glucksman MJ; Wilkie AO; García-Minaur S; Heath KE
    Am J Med Genet A; 2011 Dec; 155A(12):3050-3. PubMed ID: 22038757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The molecular and genetic basis of fibroblast growth factor receptor 3 disorders: the achondroplasia family of skeletal dysplasias, Muenke craniosynostosis, and Crouzon syndrome with acanthosis nigricans.
    Vajo Z; Francomano CA; Wilkin DJ
    Endocr Rev; 2000 Feb; 21(1):23-39. PubMed ID: 10696568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic screening of fibroblast growth-factor receptor 2 reveals a wide spectrum of mutations in patients with syndromic craniosynostosis.
    Kan SH; Elanko N; Johnson D; Cornejo-Roldan L; Cook J; Reich EW; Tomkins S; Verloes A; Twigg SR; Rannan-Eliya S; McDonald-McGinn DM; Zackai EH; Wall SA; Muenke M; Wilkie AO
    Am J Hum Genet; 2002 Feb; 70(2):472-86. PubMed ID: 11781872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation analysis of FGFR1-3 in 11 Japanese patients with syndromic craniosynostoses.
    Ohishi A; Nishimura G; Kato F; Ono H; Maruwaka K; Ago M; Suzumura H; Hirose E; Uchida Y; Fukami M; Ogata T
    Am J Med Genet A; 2017 Jan; 173(1):157-162. PubMed ID: 27683237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and genetic characteristics of craniosynostosis in Hungary.
    Bessenyei B; Nagy A; Szakszon K; Mokánszki A; Balogh E; Ujfalusi A; Tihanyi M; Novák L; Bognár L; Oláh É
    Am J Med Genet A; 2015 Dec; 167A(12):2985-91. PubMed ID: 26289989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mild achondroplasia/hypochondroplasia with acanthosis nigricans, normal development, and a p.Ser348Cys FGFR3 mutation.
    Couser NL; Pande CK; Turcott CM; Spector EB; Aylsworth AS; Powell CM
    Am J Med Genet A; 2017 Apr; 173(4):1097-1101. PubMed ID: 28181399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expanding the phenotype for the recurrent p.Ala391Glu variant in FGFR3: Beyond crouzon syndrome and acanthosis nigricans.
    Rymer K; Shiang R; Hsiung A; Pandya A; Bigdeli T; Webb BT; Rhodes J
    Mol Genet Genomic Med; 2019 Jun; 7(6):e656. PubMed ID: 31016899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Description of a new mutation and characterization of FGFR1, FGFR2, and FGFR3 mutations among Brazilian patients with syndromic craniosynostoses.
    Passos-Bueno MR; Sertié AL; Richieri-Costa A; Alonso LG; Zatz M; Alonso N; Brunoni D; Ribeiro SF
    Am J Med Genet; 1998 Jul; 78(3):237-41. PubMed ID: 9677057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prominent basal emissary foramina in syndromic craniosynostosis: correlation with phenotypic and molecular diagnoses.
    Robson CD; Mulliken JB; Robertson RL; Proctor MR; Steinberger D; Barnes PD; McFarren A; Müller U; Zurakowski D
    AJNR Am J Neuroradiol; 2000 Oct; 21(9):1707-17. PubMed ID: 11039354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular diagnosis of bilateral coronal synostosis.
    Mulliken JB; Steinberger D; Kunze S; Müller U
    Plast Reconstr Surg; 1999 Nov; 104(6):1603-15. PubMed ID: 10541159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibroblast growth factor receptor 3 (FGFR3) transmembrane mutation in Crouzon syndrome with acanthosis nigricans.
    Meyers GA; Orlow SJ; Munro IR; Przylepa KA; Jabs EW
    Nat Genet; 1995 Dec; 11(4):462-4. PubMed ID: 7493034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated strategy for fast and automated molecular characterization of genes involved in craniosynostosis.
    Stenirri S; Restagno G; Ferrero GB; Alaimo G; Sbaiz L; Mari C; Genitori L; Maurizio F; Cremonesi L
    Clin Chem; 2007 Oct; 53(10):1767-74. PubMed ID: 17693524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early mandibular morphological differences in patients with FGFR2 and FGFR3-related syndromic craniosynostoses: A 3D comparative study.
    Morice A; Cornette R; Giudice A; Collet C; Paternoster G; Arnaud É; Galliani E; Picard A; Legeai-Mallet L; Khonsari RH
    Bone; 2020 Dec; 141():115600. PubMed ID: 32822871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muenke syndrome: An international multicenter natural history study.
    Kruszka P; Addissie YA; Yarnell CM; Hadley DW; Guillen Sacoto MJ; Platte P; Paelecke Y; Collmann H; Snow N; Schweitzer T; Boyadjiev SA; Aravidis C; Hall SE; Mulliken JB; Roscioli T; Muenke M
    Am J Med Genet A; 2016 Apr; 170A(4):918-29. PubMed ID: 26740388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of severe achondroplasia with developmental delay and acanthosis nigricans by the p.Thr651Pro mutation.
    Manickam K; Donoghue DJ; Meyer AN; Snyder PJ; Prior TW
    Am J Med Genet A; 2014 Jan; 164A(1):243-50. PubMed ID: 24352917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotype and clinical care correlations in craniosynostosis: findings from a cohort of 630 Australian and New Zealand patients.
    Roscioli T; Elakis G; Cox TC; Moon DJ; Venselaar H; Turner AM; Le T; Hackett E; Haan E; Colley A; Mowat D; Worgan L; Kirk EP; Sachdev R; Thompson E; Gabbett M; McGaughran J; Gibson K; Gattas M; Freckmann ML; Dixon J; Hoefsloot L; Field M; Hackett A; Kamien B; Edwards M; Adès LC; Collins FA; Wilson MJ; Savarirayan R; Tan TY; Amor DJ; McGillivray G; White SM; Glass IA; David DJ; Anderson PJ; Gianoutsos M; Buckley MF
    Am J Med Genet C Semin Med Genet; 2013 Nov; 163C(4):259-70. PubMed ID: 24127277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic variability in Muenke syndrome-observations from five Danish families.
    Öwall L; Kreiborg S; Dunø M; Hermann NV; Darvann TA; Hove H
    Clin Dysmorphol; 2020 Jan; 29(1):1-9. PubMed ID: 31609728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct missense mutations of the FGFR3 lys650 codon modulate receptor kinase activation and the severity of the skeletal dysplasia phenotype.
    Bellus GA; Spector EB; Speiser PW; Weaver CA; Garber AT; Bryke CR; Israel J; Rosengren SS; Webster MK; Donoghue DJ; Francomano CA
    Am J Hum Genet; 2000 Dec; 67(6):1411-21. PubMed ID: 11055896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expansion of the variable expression of Muenke syndrome: Hydrocephalus without craniosynostosis.
    González-Del Angel A; Estandía-Ortega B; Alcántara-Ortigoza MA; Martínez-Cruz V; Gutiérrez-Tinajero DJ; Rasmussen A; Gómez-González CS
    Am J Med Genet A; 2016 Dec; 170(12):3189-3196. PubMed ID: 27568649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skeletal analysis of the Fgfr3(P244R) mouse, a genetic model for the Muenke craniosynostosis syndrome.
    Twigg SR; Healy C; Babbs C; Sharpe JA; Wood WG; Sharpe PT; Morriss-Kay GM; Wilkie AO
    Dev Dyn; 2009 Feb; 238(2):331-42. PubMed ID: 19086028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.